Colistin Ban is highly demanded by the Doctors

Infectious disease experts are forcing the central government to put a ban on the use of colistin, an antibiotic widely used to promote growth in fish and animals. Recently study reports found around 50% of the meat, vegetables, and fruit sold in the retail market contained bacteria resistant to the drug.

Colistin exists in the market since the 1950s but rarely used because it causes kidney problems. Colistin has been given to the patients who don’t respond to other antibiotics but it has side-effects.

Dr. Abdul Ghafur shared his study results on the presence of this colistin-resistant bacteria called Klebsiella pneumoniae in chicken, fish and vegetables picked from shops and house kitchens. He shared his concerns and worries at the European Congress of Clinical Microbiology and Infectious Diseases in Madrid to aware people and notify government to take action immediately.

The usage of Colistin antibiotic has spread farther than anticipated and this is the right time to stop ban otherwise it will cause serious harm to the society. The over usage of this made body bacteria drug-resistant. Researchers and medical literature are giving a wakeup call to the government to put a ban on it.  Dr. Ghafur also shared that don’t panic yet, but we need to worry about its usage as changing food habits will not work. He also informed that the China government also banned this antibiotic in the country to save citizens from its adverse side-effects and the Indian government should also need to act fast and ban it immediately.

High heat has the power to kill that bacteria that’s why meat dishes are safe but the possibility of infections is there.

 

 

Related Posts

Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

Patients for Patient Safety Foundation (PFPSF) Partners with CAHO to RollOut an Excellence Program New Delhi: Thanks to some well-meaning organizations, patients are going to be lord of all they…

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore